GLP-1 medications like Ozempic® and Wegovy® are widely used for type 2 diabetes and, increasingly, for medical weight management. As their use grows, so do questions about GLP-1 and eating disorders, particularly how appetite-suppressing drugs might interact with conditions that involve disrupted hunger cues, restrictive behaviors, or cycles of bingeing and compensatory actions. 

The rapid rise of GLP-1 medications like semaglutide and tirzepatide has reshaped conversations about weight, health and appetite…but a lot of research hasn’t been done on these new drugs. Also, the bulk of GLP-1 research has focused on these medications and binge eating disorder. 

Still, this emerging class of medications has also opened a complex and often overlooked dialogue about eating disorders. As these drugs become more widely used for weight loss and metabolic conditions, clinicians and individuals alike are grappling with questions about how appetite-suppressing medications intersect with disordered eating patterns, body image concerns and recovery. 

How GLP-1 Medications Like Semaglutide Work 

GLP-1 medications mimic a naturally occurring hormone called glucagon-like peptide-1. After you eat, GLP-1 signals the brain and pancreas to help regulate blood sugar and appetite. These medicines are most often given as weekly or daily injections, though some are available in oral form. 

They are commonly prescribed to: 

  • Manage type 2 diabetes by lowering blood sugar and reducing the risk of cardiovascular complications. 
  • Support medical treatment of “obesity” with related conditions under close medical supervision. 

How they work: 

  • They slow gastric emptying, which can increase fullness after meals. 
  • Increase insulin secretion when blood sugar is high. 
  • Decrease glucagon release, helping stabilize blood glucose. 
  • Act on reward centers in the brain to help reduce cravings and enhance satiety. 

Tirzepatide is a GLP-1 dual agonist that activates two receptors to treat type 2 diabetes and promote weight loss. Mounjaro® is the brand name for the type of tirzepatide used to treat diabetes; Zepbound® is prescribed for weight loss. 

It’s important to remember that GLP-1 is dose-dependent, meaning that many of the side effects are experienced by those taking larger doses of these prescription medications. GLP-1 drugs can be very helpful for people with diabetes and other conditions. 

What Are Some Common GLP-1 Medications? 

Common GLP-1 medications include: 

  • Ozempic (semaglutide) and Wegovy {semaglutide): These are the same medications but come in different doses depending on what they’re intended for. Ozempic is used for blood sugar control; Wegovy is used for weight management. 
  • Mounjaro (tirzepatide): Used for diabetes management 
  • Saxenda® (liraglutide): Used for weight management 
  • Zepbound (tirzepatide): Used for weight management 

The Impact of GLP-1 Appetite Suppressants on Disordered Eating

Because these medications directly affect appetite and satiety, they can change eating patterns and food thoughts. Some people notice fewer hunger cues, earlier fullness, or less preoccupation with food. 

For others, particularly those with a history of disordered eating, a GLP-1 appetite suppressant effect can complicate recovery by reinforcing restrictive patterns or making it harder to follow a meal plan. 

Potential risks for those with an eating disorder include: 

  • These drugs can make recognizing (and responding) to the body’s natural hunger cues much harder, which is a major step in recovery. 
  • Because GLP-1 medications can make you feel full, they can reinforce unhelpful thoughts such as eating enough food, skipping meals, or ignoring hunger signals. 

Side effects like indigestion, nausea and GI complications can make structured eating habits harder to maintain. Also, GLP-1 impacts different eating disorders in different ways: 

  • Binge Eating: GLP-1 can reduce bingeing episodes…but it also doesn’t address the complex psychological and/or emotional triggers that can cause bingeing sessions. 
  • Purging Behaviors: Because GLP-1 slows stomach emptying, nausea and other stomach issues are side effects. In turn, this can cause people to increase purging behaviors like using laxatives and vomiting, which can cause serious physical complications. 
  • Restriction: GLP-1 can contribute to malnutrition and electrolyte imbalances because its effects on appetite can make restrictive eating and weight loss more severe.Any medicine that alters hunger cues, including GLP-1 meds for weight loss, should be approached with caution and coordinated care when there are concerns about GLP-1 and eating disorders. 

Regular therapy, open check-ins about thoughts and urges, and tracking non-scale wins, like improved concentration and flexibility with food and engagement in life, are more likely to help create a lasting, healthy future. 

Navigating Diet Culture 

Diet culture prioritizes thinness, promises fast results and often moralizesfood choices. The public conversation around GLP-1 meds for weight loss can intensify pressure to pursue weight changes at any cost. For someone vulnerable to disordered eating, this atmosphere can trigger comparisons, secrecy, and shame. 

Weight stigma, bias, or discrimination based on body size can worsen eating disorders by lowering self-worth, deterring people from seeking care, and reinforcing restrictive or compensatory behaviors. This can influence decision-making, pushing people toward quick fixes rather than comprehensive care addressing medical, nutritional, and psychological needs. 

It is especially important to consider these factors when navigating GLP-1 and eating disorders. 

Supportive strategies include: 

  • Building media literacy around weight-loss headlines and wellness trends. 
  • Curating a body-inclusive social media feed with diverse voices. 
  • Prioritizing health-promoting habits like regular meals, joyful movement, sleep and stress management over appearance-based goals. 
  • Practicing self-compassion and recognizing how food supports energy, mood, cognition and relationships. 
  • Setting boundaries around weight talk in social and family settings. 

Loved ones can help by using neutral language about bodies, celebrating strengths that have nothing to do with appearance, and supporting consistent, satisfying meals without judgment.

Treatment That Supports the Whole Person 

Effective eating disorder treatment integrates therapy, nutritional counseling, medical monitoring, and family or community support. Therapy often includes: 

  • Family-based treatment 
  • Trauma-informed care 

Nutritional counseling focuses on restoring regular eating patterns, rebuilding trust in hunger and fullness cues, and reducing rigid food rules. 

Creating a supportive environment matters. This includes predictable meals and snacks, flexibility at school or work to accommodate appointments and meal timing, and compassionate communication that reduces shame and blame. 

Balancing Risks and Benefits 

GLP-1 medications can be helpful for specific medical needs. They can also complicate recovery if they are not carefully managed. The decision to start, continue or stop a GLP-1 is highly individual and best made with a multidisciplinary team familiar with GLP-1 and eating disorders. 

Key questions to discuss with your team: 

  • What medical goals are you targeting, and how will we measure them beyond weight? 
  • How might this medication affect my hunger cues and adherence to my meal plan? 
  • What supports are in place if anxiety or compulsive thoughts increase? 
  • What is the plan for side effects, missed doses or discontinuation? 
  • How will care be coordinated across medical, nutrition and therapy providers? 

For anyone with current or past disordered eating, treatment works best when medical care, nutrition support and therapy progress together. 

Struggling with Your Self-Image? We’ll Help You 

Center for Discovery provides measurement-based care for eating disorders with comprehensive teams who collaborate on complex cases, including those involving GLP-1 and eating disorders. 

If you are exploring options or have questions about GLP-1 medications and/or your relationship with eating, contact us to learn more about levels of care, insurance coverage, and how we can tailor a plan that supports long-term recovery. 

Frequently Asked Questions 

Can GLP-1 trigger or worsen an eating disorder? 

It can do both. Appetite suppression and early fullness may reinforce restriction or anxiety around eating, especially without therapy and nutrition support. 

If binge urges decrease, does that mean my eating disorder is gone? 

Not necessarily. Medication can reduce urges but underlying emotional and behavioral factors still need treatment. 

Is it safe to use GLP-1 during recovery? 

It depends. With clear goals, close monitoring, and a plan for side effects and dose changes, some people can use these medicines safely. Coordination among providers is essential. 

What if my appetite rebounds after stopping the medication? 

Work with your team on a transition plan that includes meal structure, coping skills, and extra support to manage changes in hunger and fullness.